These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 16051634

  • 1. Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway.
    Lin CC, Tsai YL, Huang MT, Lu YP, Ho CT, Tseng SF, Teng SC.
    Carcinogenesis; 2006 Jan; 27(1):131-6. PubMed ID: 16051634
    [Abstract] [Full Text] [Related]

  • 2. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.
    Kyprianou N, English HF, Davidson NE, Isaacs JT.
    Cancer Res; 1991 Jan 01; 51(1):162-6. PubMed ID: 1899037
    [Abstract] [Full Text] [Related]

  • 3. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J, Slivova V, Sliva D.
    Int J Oncol; 2006 Sep 01; 29(3):695-703. PubMed ID: 16865287
    [Abstract] [Full Text] [Related]

  • 4. Estrogen dependent regulation of estrogen receptor gene expression in normal mammary gland and its relationship to estrogenic sensitivity.
    Shyamala G, Schneider W, Guiot MC.
    Receptor; 1992 Sep 01; 2(2):121-8. PubMed ID: 1472945
    [Abstract] [Full Text] [Related]

  • 5. Mechanistic studies on the inhibitory action of dietary dibenzoylmethane, a beta-diketone analogue of curcumin, on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis.
    Lin CC, Ho CT, Huang MT.
    Proc Natl Sci Counc Repub China B; 2001 Jul 01; 25(3):158-65. PubMed ID: 11480771
    [Abstract] [Full Text] [Related]

  • 6. Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells.
    Yu Y, Zhou Q, Hang Y, Bu X, Jia W.
    Cancer; 2007 Jun 01; 109(11):2374-82. PubMed ID: 17464948
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH.
    Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1221-6. PubMed ID: 16169518
    [Abstract] [Full Text] [Related]

  • 9. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
    Liu J, Li J, Sidell N.
    Cancer Chemother Pharmacol; 2007 Feb 04; 59(2):217-25. PubMed ID: 16738884
    [Abstract] [Full Text] [Related]

  • 10. Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
    Boggess JF, Zhou C, Bae-Jump VL, Gehrig PA, Whang YE.
    Gynecol Oncol; 2006 Nov 04; 103(2):417-24. PubMed ID: 16690106
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M, Tsuji N, Kobayashi D, Kuribayashi K, Watanabe N.
    Int J Oncol; 2009 May 04; 34(5):1363-72. PubMed ID: 19360348
    [Abstract] [Full Text] [Related]

  • 12. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R, Hanf V, Emons G, Gründker C.
    J Pineal Res; 2009 Aug 04; 47(1):23-31. PubMed ID: 19522736
    [Abstract] [Full Text] [Related]

  • 13. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity.
    Zhang PH, Zou L, Tu ZG.
    J Surg Res; 2006 Mar 04; 131(1):143-9. PubMed ID: 16298398
    [Abstract] [Full Text] [Related]

  • 14. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Exp Biol Med (Maywood); 2007 Sep 04; 232(8):1071-80. PubMed ID: 17720953
    [Abstract] [Full Text] [Related]

  • 15. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.
    Hirsch K, Atzmon A, Danilenko M, Levy J, Sharoni Y.
    Breast Cancer Res Treat; 2007 Aug 04; 104(2):221-30. PubMed ID: 17051425
    [Abstract] [Full Text] [Related]

  • 16. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
    Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM.
    Cancer Res; 2001 Oct 15; 61(20):7456-63. PubMed ID: 11606380
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM, Fang DC, Yang JL, Chen L, Luo YH, Liang GP.
    Eur J Cancer Prev; 2008 Jun 15; 17(3):209-17. PubMed ID: 18414191
    [Abstract] [Full Text] [Related]

  • 19. Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
    Zheng ZY, Zheng SM, Bay BH, Aw SE, C-L Lin V.
    Breast Cancer Res Treat; 2008 Jul 15; 110(1):111-25. PubMed ID: 17687644
    [Abstract] [Full Text] [Related]

  • 20. Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations.
    Ju YH, Allred KF, Allred CD, Helferich WG.
    Carcinogenesis; 2006 Jun 15; 27(6):1292-9. PubMed ID: 16537557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.